rs6075209

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_002594.5(PCSK2):​c.710-2134G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.353 in 151,992 control chromosomes in the GnomAD database, including 9,930 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.35 ( 9930 hom., cov: 31)

Consequence

PCSK2
NM_002594.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.237

Publications

2 publications found
Variant links:
Genes affected
PCSK2 (HGNC:8744): (proprotein convertase subtilisin/kexin type 2) This gene encodes a member of the subtilisin-like proprotein convertase family, which includes proteases that process protein and peptide precursors trafficking through regulated or constitutive branches of the secretory pathway. The protein undergoes an initial autocatalytic processing event and interacts with a neuroendocrine secretory protein in the ER, exits the ER and sorts to secretory granules, where it is cleaved and catalytically activated during intracellular transport. The encoded protease is packaged into and activated in dense core secretory granules and expressed in the neuroendocrine system and brain. This gene encodes one of the seven basic amino acid-specific members which cleave their substrates at single or paired basic residues. It functions in the proteolytic activation of polypeptide hormones and neuropeptides precursors. Single nucleotide polymorphisms in this gene may increase susceptibility to myocardial infarction and type 2 diabetes. This gene may also play a role in tumor development and progression. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Jan 2014]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.555 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002594.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PCSK2
NM_002594.5
MANE Select
c.710-2134G>A
intron
N/ANP_002585.2
PCSK2
NM_001201528.2
c.653-2134G>A
intron
N/ANP_001188457.1
PCSK2
NM_001201529.3
c.605-2134G>A
intron
N/ANP_001188458.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PCSK2
ENST00000262545.7
TSL:1 MANE Select
c.710-2134G>A
intron
N/AENSP00000262545.2
PCSK2
ENST00000377899.5
TSL:1
c.653-2134G>A
intron
N/AENSP00000367131.1
PCSK2
ENST00000536609.1
TSL:2
c.605-2134G>A
intron
N/AENSP00000437458.1

Frequencies

GnomAD3 genomes
AF:
0.353
AC:
53568
AN:
151874
Hom.:
9930
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.255
Gnomad AMI
AF:
0.411
Gnomad AMR
AF:
0.299
Gnomad ASJ
AF:
0.356
Gnomad EAS
AF:
0.304
Gnomad SAS
AF:
0.573
Gnomad FIN
AF:
0.360
Gnomad MID
AF:
0.367
Gnomad NFE
AF:
0.409
Gnomad OTH
AF:
0.385
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.353
AC:
53583
AN:
151992
Hom.:
9930
Cov.:
31
AF XY:
0.355
AC XY:
26367
AN XY:
74272
show subpopulations
African (AFR)
AF:
0.255
AC:
10556
AN:
41436
American (AMR)
AF:
0.298
AC:
4564
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.356
AC:
1235
AN:
3470
East Asian (EAS)
AF:
0.304
AC:
1573
AN:
5170
South Asian (SAS)
AF:
0.572
AC:
2745
AN:
4796
European-Finnish (FIN)
AF:
0.360
AC:
3794
AN:
10544
Middle Eastern (MID)
AF:
0.381
AC:
112
AN:
294
European-Non Finnish (NFE)
AF:
0.409
AC:
27827
AN:
67978
Other (OTH)
AF:
0.382
AC:
804
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1748
3496
5245
6993
8741
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
540
1080
1620
2160
2700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.380
Hom.:
14022
Bravo
AF:
0.337
Asia WGS
AF:
0.394
AC:
1370
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
2.4
DANN
Benign
0.73
PhyloP100
0.24
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6075209; hg19: chr20-17415219; API